Effectiveness of Non-invasive Neuromodulation in Patients With Long-COVID

NARecruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Long-COVIDPost-acute COVID-19 Syndrome
Interventions
DEVICE

Non-invasive neuromodulation

The treatment plan of non- invasive neuromodulation will be applied for two months, with a frequency of 2 weekly sessions of one hour duration, until completing a total of 15 sessions for each patient. The sessions will always be applied in the same time slot of the day (to avoid influence on the measurements, specially cortisol).

OTHER

Placebo

The treatment plan of placebo will be applied for two months, with a frequency of 2 weekly sessions of one hour duration, until completing a total of 15 sessions for each patient. Participants will be attached to the neuromodulation machine, however, the cable will not be connected. Participants will not be able to see the machine connections. The sessions will always be applied in the same time slot of the day (to avoid influence on the measurements, specially cortisol).

Trial Locations (1)

28922

RECRUITING

Rey Juan Carlos University, Alcorcón

All Listed Sponsors
lead

Universidad Rey Juan Carlos

OTHER